Status:

COMPLETED

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Lead Sponsor:

Fox Chase Cancer Center

Conditions:

Non Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Needle biopsy samples are routinely collected to evaluate cytomorphology, immunohistochemical markers and for mutational analysis. With regular use of immunotheraputic interventions, needle biospy has...

Detailed Description

Primary Objective To compare the diagnostic yield of 22g and 19g EBUS transbronchial needle aspirate (TBNA) Secondary Objectives 1. To compare the sample adequacy of 22g and 19g EBUS TBNA 2. To comp...

Eligibility Criteria

Inclusion

  • Patients undergoing EBUS TBNA for evaluation of lymphadenopathy, lung nodule or mass
  • Patients must have atypical lymph nodes. Atypical lymph nodes are characterized by \>10mm in short axis or lymph nodes 5-10mm in short axis with atypical features.
  • Age \> 18 years.
  • Patients must have platelets count \> 50,000
  • Ability to understand and willingness to sign a written informed consent and HIPAA consent document
  • WOCBP must agree not to get pregnant until the day of the procedure

Exclusion

  • Patients with uncorrectable coagulopathy will be excluded.
  • Patients with hemodynamic instability will be excluded
  • Patients with refractory hypoxemia will be excluded
  • Patients with therapeutic anticoagulant that cannot be held for 2 days before and 1 day after the procedure.
  • Patients who are unable to tolerate general anesthesia according to the anesthesiologist
  • Pregnant or breast feeding.

Key Trial Info

Start Date :

May 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 8 2020

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03311620

Start Date

May 15 2018

End Date

June 8 2020

Last Update

October 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fox Chase Cancer Center

Philadelphia, Pennsylvania, United States, 19111